Genetic factors in aminoglycoside toxicity

Pharmacogenomics

Volumn 6, Issue 1, 2005, Pages 27-36

  Fischel Ghodsian, Nathan ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Aminoglycosides; Maternally inherited deafness; Mitochondrial mutations; Ototoxicity; Pharmacogenomics

Indexed keywords

AMINOGLYCOSIDE; EAR DROPS; GENTAMICIN; GLYCOPROTEIN P; IMATINIB; KANAMYCIN; MITOCHONDRIAL RNA; N METHYL DEXTRO ASPARTIC ACID; NEOMYCIN; NEUROTROPHIC FACTOR; NUCLEAR FACTOR; PHOSPHOLIPID; STREPTOMYCIN; TOBRAMYCIN;

3' UNTRANSLATED REGION; AUTOSOMAL RECESSIVE INHERITANCE; COCHLEA; DRUG BLOOD LEVEL; ETHNIC DIFFERENCE; EXTRACHROMOSOMAL INHERITANCE; FAMILY HISTORY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HEREDITY; HUMAN; KIDNEY DISEASE; MENINGITIS; MICROBIAL ACTIVITY; MOLECULAR CLONING; MOLECULAR GENETICS; MULTIFACTORIAL INHERITANCE; MUTATIONAL ANALYSIS; NONHUMAN; OTOTOXICITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PEDIGREE; PHENOTYPE; PREVALENCE; REVIEW; RISK ASSESSMENT; RNA GENE; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SINGLE DRUG DOSE; TISSUE SPECIFICITY; TUBERCULOSIS;

AMINOGLYCOSIDES; EAR DISEASES; HEARING LOSS; HUMANS; MUTATION;

EID: 13544261687     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.6.1.27     Document Type: Review

References (89)

1. Sande MA, Mandell GL: Antimicrobial agents. In: The Pharmacological Basis of Therapeutics (8th edn). Gilman AG, Rall TW, Nies AS, Taylor P (Eds), Pergamon Press, Inc., Elmsford, NY, USA 1098-1116 (1990).
2. Lortholary O, Tod M, Cohen Y, Petitjean O: Aminoglycosides. Med. Clin. North Am. 79, 761-798 (1995).
3. Price KE: Aminoclycoside research 1975-1985: prospects for development of improved agents. Antimicrobial Agents Chemother. 29, 543-548 (1986).
4. Prazic M, Salaj B: Ototoxicity with children caused by streptomycin. Audiology 14, 173-176 (1975).
5. Ryback LP: Drug ototoxicity. Annu. Rev. Pharmacol. Toxicol. 26, 79-99 (1986).
6. Moore RD, Smith CR, Lietman PS: Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J. Infect. Dis. 149, 23-30 (1984).
7. McGee TM, Olszewski J: Streptomycin sulfate and dihydrostreptomycin toxicity. Behavioural and histopathologic studies. Arch. Otolaryngol. 75, 295-311 (1962).
8. Wersall J: Structural damage of the organ of Corti and the vestibular epithelia caused by aminoglycoside antibiotics in the guinea-pig. In: Aminoglycoside Ototoxicity. Lerner SA, Matz GJ, Hawkins JE Jr (Eds), Little, Brown & Co., Boston, MA, USA 197-214 (1981).
9. Hinojosa R, Lerner SA. Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity. J. Infect. Dis. 156(3), 449-455 (1987).
10. Duvall AJ, Wersall J: Site of action of streptomycin upon inner ear sensory cells. Acta Otolaryngol. 57, 581-598 (1964).
11. Darrouzet J, Guilhaume A: [Ototoxicite de la kanamycin au jour le jour. Etude experimentale en microscopie electronique.] Rev. Laryngol. Otol. Rhinol. 95, 601-621 (1974).
12. De Groot JC, Huizing EH, Veldman JE: Early structural effects of gentamicin cochleotoxicity. Acta Otolaryngol. 111, 273-280 (1991).
13. Nuttall AL, Marques DM, Lawrence M: Effects of perilymphatic perfusion with neomycin on the cochlear microphonic potential in the guinea-pig. Acta Otolaryngol. 83, 393-400 (1977).
14. Kroese ABA, Das A, Hudspeth AJ: Blockage of the transduction channels of hair cells in the bullftog's sacculus by aminoglycoside antibiotics. Hear. Res. 37, 203-217 (1989).
15. Puel JL, Lenoir M, Uziel A: Dose-dependent changes in the rat cochlea following aminoglycoside intoxication. I. Physiological study. Hear. Res. 26, 191-197 (1987).
16. Vrabec DP, Cody DT, Ulrich JA: A study of the relative concentrations of antibiotics in the blood, spinal fluid and perilymph in animals. Ann. Otol. Rhinol. Laryngol. 74, 689 (1965).
17. Henley CM, Schacht J: Pharmacokinetics of aminoglycoside antibiotics in blood, inner-ear fluids and tissues and their relationship to ototoxicity. Audiology 27, 137-146 (1988).
18. Lim DJ: A review: effects of noise and ototoxic drugs at the cellular level in the cochlea. Am. J. Otolaryngol. 7, 73-99 (1986 ).
19. Schacht J: Phosphoinositides in the auditory system. Nobel Symposium 63: Cellular Mechnisms in Hearing en Hommage a Georg von Bekesy 26 (1985) (Abstract).
20. Williams SE, Zenner HP, Schacht J: Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear. Res. 30, 11-18 (1987).
21. Jarlstedt J, Bagger-Sjoback D: Gentamicin-induced changes in RNA content in sensory and ganglionic cells in the hearing organ of the lizard Calotes versicolor: a cytochemical and morphological investigation. Acta Otolaryngol 84, 361-369 (1977).
22. Stockhorst W, Schacht J: Radioactive labelling of phospholipids and proteins by cochlear perfusion in the guinea-pig and the eff-ect of neomycin. Acta Otolaryngol. 83, 401-409 (1977).
23. Song BB, Schacht J: Variable efficacy of radical scavengers and iron chelators to attenuate gentamycin ototoxicity in guinea pigs in vivo. Hear. Res. 94, 87-93 (1996).
24. Ingram VM: Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180, 326 (1957).
25. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36, 93-99 (1984).
26. de The H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347, 558-561 (1990).
27. Castaigne S, Chomienne C, Daniel MT et al.: All- trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 76, 1704-1709 (1990).
28. Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M: Philadelphia chromosome-positive leukaemias: from basic mechanisms to molecular therapeutics. Ann. Internal Med. 138, 819-830 (2003).
29. Stringer SP, Meyerhoff WL, Wright CG: Ototoxicity. In: Otolaryngology (3rd edn). Paparella WM, Shumrick DA, Gluckman JL, Meyerhoff WL (Eds), W.B. Saunders Co., Philadelphia, PA, USA 1653-1669 (1991).
30. Higashi K: Unique inheritance of streptomycin-induced deafness. Clin. Genet. 35, 433-436 (1989).
31. Prazic M, Salaj B, Subotic R: Familial sensitivity to streptomycin. J. Laryngol. Otol. 78, 1037-1043 (1964).
32. Tsuiki T, Murai S: Familial incidence of streptomycin hearing loss and hereditary weakness of the cochlea. Audiology 10, 315-322 (1971).
33. Konigsmark BW, Gorlin RJ: Genetic and Metabolic Deafness W.B. Saunders Co., Philadelphia, PA, USA 364-365 (1976).
34. Hu D-N, Qiu W-Q, Wu B-T et al.: Genetic aspects of antibiotic induced deafness: mitochondrial inheritance. J. Med. Genet. 28, 79-83 (1991).
35. Stebbins WC, McGinn CS, Feitosa AG et al.: Animal models in the study of ototoxic hearing loss. In: Aminoglycoside Ototoxicity. Lerner SA, Matz GL, Hawkins JE Jr (Eds), Little, Brown and Co., Boston, MA, USA, 5-25 (1981).
36. Hornig H, Woolley P, Luhrmann R. Decoding at the ribosomal A site: antibiotics, misreading and energy of aminoacyl-tRNA binding. Biochimie 69, 803-813 (1987).
37. Davis J, Davis BD: Misreading of ribonucleic acid code words induced by aminoglycoside antibiotics. J. Biol. Chem. 243, 3312-3316 (1968).
38. Noller HF: Ribosomal RNA and translation. Annu. Rev. Biochem. 60, 191-227 (1991).
39. Prezant TR, Agapian JV, Bohlman MC et al.: Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 4, 289-294 (1993).
40. Gravel M, Melancon P, Brakier-Gingras L: Crosslinking of streptomycin to the 16S ribosomal RNA of Escherichia coli. Biochemistry 26, 6227-6232 (1987).
41. Li M, Tzagaloff A, Underbrink-Lyon K, Martin NC: Identification of the paromomycin-resistance mutation in the 15S rRNA gene of yeast mitochondria. J. Biol. Chem. 257, 5921-5928 (1982).
42. Spangler EA, Blackburn EH: The nucleotide sequence of the 17S ribosomal RNA gene of Tetrahymena thermophila and the identification of point mutations resulting in resistance to the antibiotics paromomycin and hygromycin. J. Biol. Chem. 260, 6334-6340 (1985).
43. Hutchin T, Haworth I, Higashi K et al.: A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucleic Acids Res. 21, 4174-4179 (1993).
44. Matthijs G, Claes S, Longo-Mbenza B, Cassiman J-J: Non-syndromic deafness associated with a mutation and a polymorphism in the mitochondrial 12S ribosomal RNA gene in a large Zairean pedigree. Eur. J. Hum. Genet. 4, 46-51 (1996).
45. Pandya A, Xia X, Radnaabazar J et al.: Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J. Med. Genet. 34, 169-172 (1997).
46. El-Schahawi M, deMunain L, Sarrazin AM et al.: Two large Spanish pedigrees with non-syndromic sensorineural deafness and the mtDNA mutation at nt 1555 in the 12SrRNA gene: evidence of heteroplasmy. Neurology 48, 453-456 (1997).
47. Estivill X, Govea N, Barcelo A et al.: Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am. J. Hum. Genet. 62, 27-35 (1998).
48. Shohat M, Fischel-Ghodsian N, Legum C, Halpern GJ: Aminoglycoside induced deafness in an Israeli Jewish family with a mitochondrial ribosomal RNA gene mutation. Am. J. Otolaryngol. 20, 64-67 (1999).
49. Li R, Xing G, Yan M et al: Cosegregation of C-insertion at position 961 with A1555G mutation of mitochondrial 12S rRNA gene in a large Chinese family with maternally inherited hearing loss. Am. J. Med. Genet. 124A, 113-117 (2004).
50. Fischel-Ghodsian N, Prezant TR, Bu X, Oztas S: Mitochondrial ribosomal RNA mutation associated with aminoglycoside ototoxicity. Am. J. Otolaryngol. 14, 399-403 (1993).
51. Fischel-Ghodsian N, Prezant TR, Chaltraw W et al.: Mitochondrial gene mutations: a common predisposing factor in aminoglycoside ototoxicity. Am. J. Otolaryngol. 18, 173-178 (1997 ).
52. del Castillo FJ, Rodriguez-Ballesteros M, Martin Y et al. Heteroplasmy for the 1555A > G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss: implications for genetic diagnosis and counseling. J. Med. Genet. 40, 632-636 (2003).
53. Casano RAMS, Bykhovskaya Y, Johnson DF, Torricelli F, Bigozzi M, Fischel-Ghodsian N: Hearing loss due to the mitochondrial A1555G mutation in Italian families. Am. J. Med. Genet. 79, 388-391 (1998).
54. Fischel-Ghodsian N: Mitochondrial genetics and hearing loss - the missing link between genotype and phenotype. Proc. Soc. Exp. Biol. Med. 218, 1-6 (1998).
55. Fischel-Ghodsian N: Mitochondrial mutations and hearing loss - paradigm for mitochondrial genetics. Am. J. Hum. Genet. 62, 15-19 (1998).
56. Bykhovskaya Y, Estivill X, Taylor K et al.: Candidate locus for a nuclear modifier gene for maternally inherited deafness. Am. J. Hum. Genet. 66, 1905-1910 (2000).
57. Bykhovskaya Y, Yang H, Taylor K et al.: Linkage and linkage disequilibrium mapping of a nuclear modifier gene for maternally inherited deafness. Genet. Med. 3, 177-180 (2001).
58. Bykhovskaya Y, Mengesha E, Wang D et al.: Human mitochondrial transcription factor B1 as a modifier gene for hearing loss associated with the mitochondrial A1555G mutation. Mol. Genet. Metab. 82, 27-32 (2004).
59. Bykhovskaya Y, Mengesha E, Wang D et al.: Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3. Mol. Genet. Metab. 83, 199-206 (2004).
60. Li X, Li R, Lin X, Guan MX: Isolation and chanracterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12S rRNA A1555G mutation. J. Biol. Chem. 277, 27256-27264 (2002).
61. Li X, Guan MX: A human mitochondrial GTP binding protein related to tRNA modification may modulate the phenotypic expression of the deafness-associated mitochondrial 12S rRNA mutation. Mol. Cell. Biol. 22, 7701-7711 (2002).
62. Bacino CM, Prezant TR, Bu X, Fournier P, Fischel-Ghodsian N: Susceptibility mutations in the mitochondrial small ribosomal RNA gene in aminoglycoside induced deafness. Pharmacogenetics 5, 165-172 (1995).
63. Casano RAMS, Johnson DF, Hamon M et al.: Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am. J. Otolaryngol. 20, 151-156 (1999).
64. Tang HY, Hutcheson E, Neill S, Drummond-Borg M, Speer M, Alford RL: Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk? Genet. Med. 4, 336-345 (2002).
65. Arnos K, Xia XJ, Norris G et al.: Relative frequencies of the mitochondrial A1555G and 961 delT mutations in the 12SrRNA gene in a large sample of deaf probands from the United States. Am. J. Hum. Genet. 73, 2196 (2003) (Abstract).
66. Zhao H, li R, Wang Q et al.: Maternally inherited aminoglycoside-induced and non-syndromic deafness associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am. J. Hum. Genet. 74, 139-152 (2004).
67. Thyagarajan D, Bressman S, Bruno C et al.: A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness and neuropathy. Ann. Neurol. 48, 730-736 (2000).
68. Tessa A, Giannotti A, Tieri L, Vilarinho L, Marotta G, Santorelli FM: Maternally inherited deafness associated with a T1095C mutation in the mDNA. Eur J. Hum. Genet. 9, 147-149 (2001).
69. Zhao L, Young W-Y, Li R, Wang Q, Qian Y, Guan M-X: Clinical evaluation and sequence analysis of the complete mitochondrial genome of three Chinese patients with hearing impairment associated with the 12S rRNA T1095C mutation. Biochem. Biophys. Red. Com. 325, 1503-1508 (2004).
70. Tanimoto H, Nishio H, Matsuo M, Nibu K-I: A novel mitochondrial mutation, 1556C→T, in a Japanese patient with streptomycin-induced tinnitus. Acta Otolaryngol. 124, 258-261 (2004).
71. Forge A, Li L, Corwin JT. Nevill G: Ultrastructural evidence for hair cell regeneration in the mammalian inner ear. Science 259, 1616-1619 (1993).
72. Warchol ME, Lambert PR, Goldstein BJ, Forge A, Corwin JT. Regenerative proliferation in inner ear sensory epithelia from adult guinea-pigs and humans. Science 259, 1619-1622 (1993).
73. Lefebvre PP, Malgrange B, Staecker H, Moonen G, van de Water TR: Retinoic acid stimulates regeneration of mammalian auditory hair cells. Science 260, 692-695 (1993).
74. Prezant TR, Chaltraw W. Fischel-Ghodsian N: Identification of an overexpressed yeast gene which prevents aminoglycoside toxicity. Microbiol. 142, 3407-3414 (1996).
75. Johnson DF, Prezant TR, Lubavin B, Chaltraw WE, Fischel-Ghodsian N: Isolation of overexpressed yeast genes which prevent aminoglycoside ototoxicity. Hear. Res. 120, 62-68 (1998).
76. Davies J, Nomura M: The genetics of bacterial ribosomes. Annu. Rev. Genet. 6, 203-234 (1972).
77. Wittmann HG, Apirion D: Analysis of ribosomal proteins in streptomycin resistant and dependent mutants isolated from streptomycin independent Escherichia coli strains. Mol. Gen. Genet. 141, 331-341 (1975).
78. Van Acken U: Protein chemical studies on ribosomal proteins S4 and S12 from ram (ribosomal ambiguity) mutants of Escherichia coli. Mol. Gen. Genet. 140, 61-68 (1975).
79. Boguta M, Dmochowska A, Borsuk P et al.: Nam9 nuclear suppressor of mitochondrial ochre mutations in Saccharomyces cerevisiae codes for a protein homologous to S4 ribosomal proteins from chloroplasts, bacteria, and eukaryotes. Mol. Cell Biol. 12(1 , 402-412 (1992).
80. Royden, CS, Pirrotta V, Jan LY. The tko locus, site of a behavioural mutation in D. melanogaster, codes for a protein homologous to prokaryotic ribosomal protein S12. Cell 51, 165-173 (1987).
81. Johnson DF, Hamon M, Fischel-Ghodsian N: Cloning and characterization of the human mitochondrial ribosomal S12 gene. Genomics 52, 363-368 (1998).
82. Hamasaki K, Rando RR: Specific binding of aminoglycosides to a human rRNA construct based on a DNA polymorphism which causes aminoglycoside-induced deafness. Biochemistry 36, 12323-12328 (1997).
83. Guan MX, Fischel-Ghodsian N, Attardi G: Biochemical evidence for nuclear gene involvement in phenotype of non-syndromic deafness associated with mitochondrial 12S rRNA mutation. Hum. Mol. Genet. 5, 963-972 (1996).
84. Guan MX, Fischel-Ghodsian N, Attardi G: A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity Hum. Mol. Genet. 9, 1787-1793 (2000).
85. 0 HeLa cells. Biochem. Biophys. Res. Commun. 223, 496-501 (1996).
86. Braverman I, Jaber L, Levi H et al.: Audio-vestibular findings in patients with deafness caused by a mitochondrial susceptibility mutation and precipitated by an inherited nuclear mutation or aminoglycosides. Arch. Otolaryngol. Head Neck Surg. 122, 1001-1004 (1996).
87. Song BB, Anderson DJ, Schacht J: Protection from gentamicin ototoxicity by iron chelators in guinea-pig in vivo. J. Pharmacol. Exp. Ther. 282, 369-377 (1997).
88. Basile S, Huang J-M, Xie C, Webster D, Berlin C, Skolnick P: N-Methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat. Med. 2, 1338-1343 (1996).
89. Ernfors P, Duan ML, ElShamy WM, Canlon B: Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3. Nat. Med. 2, 463-467 (1996).